Genomed Spolka Akcyjna Logo

Genomed Spolka Akcyjna

Biotechnology firm for genetic research and molecular diagnostics using NGS technology.

GEN | WAR

Overview

Corporate Details

ISIN(s):
PLGNOMD00024 (+3 more)
LEI:
259400MZZJNF1JFWAG26
Country:
Poland
Address:
Warszawa Ponczowa 12, 02-971 Warszawa

Description

Genomed Spolka Akcyjna is a biotechnology company specializing in genetic research and molecular diagnostics. It offers a comprehensive range of services centered on DNA and RNA sequencing, analysis, and synthesis, primarily utilizing Next Generation Sequencing (NGS) technology. The company's core activities include the analysis of gene sequences to identify mutations responsible for congenital diseases, with the capability to analyze thousands of genes. Genomed serves both the clinical diagnostics and research sectors, providing services to the medical and biotechnological markets. A key strategic focus is the development and introduction of genomic technologies into personalized medicine, aiming to advance genomic prevention and gene treatments in medical practice.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-13 18:18
Rekomendacja dotycząca podziału zysku Spółki za rok 2024 - Content (PL)
Polish 617 bytes
2024-04-15 14:45
Sprzedaż_G.Gromada
Polish 202.6 KB
2024-04-15 14:45
Powiadomienie o transakcjach na akcjach Spółki - Content (PL)
Polish 425 bytes
2024-04-12 13:38
Powiadomienie_Kupno-SPr
Polish 485.9 KB
2024-04-12 13:38
Powiadomienie o transakcjach na akcjach Spółki - Content (PL)
Polish 532 bytes
2024-01-05 12:08
Diagnostyka_Sprzedaż
Polish 5.2 KB
2024-01-05 12:08
Powiadomienie o transakcjach na akcjach Spółki - Content (PL)
Polish 414 bytes
2023-12-27 13:24
Diagnostyka_27DEC_2023
Polish 5.8 KB
2023-12-27 13:24
Powiadomienie o transakcjach na akcjach Spółki - Content (PL)
Polish 379 bytes
2023-12-27 11:10
ABC_23Dec2023
Polish 4.3 KB
2023-12-27 11:10
Powiadomienie o transakcjach na akcjach Spółki - Content (PL)
Polish 463 bytes
2023-12-21 16:20
Zgloszenie_Marek_Zagulski_23Dec_2023
Polish 4.3 KB
2023-12-21 16:20
Powiadomienie o transakcjach na akcjach Spółki - Content (PL)
Polish 416 bytes
2023-12-13 17:09
Diagnostyka_13Dec2023
Polish 5.5 KB
2023-12-13 17:09
Powiadomienie o transakcjach na akcjach Spółki - Content (PL)
Polish 409 bytes

Automate Your Workflow. Get a real-time feed of all Genomed Spolka Akcyjna filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Genomed Spolka Akcyjna

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Genomed Spolka Akcyjna via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Genprex, Inc. Logo
Clinical-stage gene therapy company developing therapies for cancer and diabetes.
United States of America
GNPX
Genxone Spolka Akcyjna Logo
A biotechnology company specializing in Next Generation Sequencing and medical diagnostics.
Poland
GX1
GeoVax Labs, Inc. Logo
Clinical-stage biotech developing vaccines and therapies for infectious diseases and cancer.
United States of America
GOVX
GH Research PLC Logo
Develops mebufotenin-based therapies for psychiatric and neurological disorders.
United States of America
GHRS
GI Innovation Inc. Logo
Researches and develops protein-based drugs for immuno-oncology and immunology.
South Korea
358570
Ginkgo Bioworks Holdings, Inc. Logo
Operates a horizontal platform for cell programming and synthetic biology.
United States of America
DNA
GRAIL, Inc. Logo
A healthcare company developing blood tests for multi-cancer early detection.
United States of America
GRAL
GT Biopharma, Inc. Logo
Clinical-stage immuno-oncology company developing therapies with its NK cell engager tech.
United States of America
GTBP
Guard Therapeutics International AB Logo
Clinical-stage biotech developing therapies to prevent acute kidney injury.
Sweden
GUARD
Gubra A/S Logo
Biotech and CRO focused on peptide drugs for metabolic and fibrotic diseases.
Denmark
GUBRA

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.